Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 27.97 USD 2.76%
Market Cap: 10.8B USD
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Revenue Breakdown

Breakdown by Geography
Moderna Inc

Total Revenue: 3.2B USD
100%
United States: 1.8B USD
55.2%
Rest Of World: 853m USD
26.4%
Europe: 598m USD
18.5%

Breakdown by Segments
Moderna Inc

Total Revenue: 3.2B USD
100%
Net Product Sales: 3.1B USD
96.1%
Covid: 3.1B USD
95.3%
Other Revenue: 127m USD
3.9%
Collaboration Revenue (Note 5): 48m USD
1.5%
Licensing And Royalty Revenue: 42m USD
1.3%
Grant Revenue: 37m USD
1.1%
Rsv: 25m USD
0.8%
Show More

See Also

Summary
MRNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRNA stock valuation using valuation multiples.
Wall Street Estimates
MRNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 250,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.